The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to “thousands” of young people this summer.

Amid the push to digitise the UK health service, a study has sounded a note of caution about entrusting important patient appointments to chatbots.

Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, confirming a breach exposed some patient data.

Novo Nordisk’s fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.

New data with Takeda’s TYK2 inhibitor zasocitinib suggest it is significantly more effective than BMS’s Sotyktu in the treatment of psoriasis.